Oregon 2023 Regular Session

Oregon Senate Bill SB1043

Introduced
2/27/23  
Refer
3/1/23  
Report Pass
4/7/23  
Engrossed
4/14/23  
Refer
4/20/23  
Report Pass
5/16/23  
Passed
7/13/23  
Chaptered
7/21/23  

Caption

Relating to opioid overdose reversal medication.

Impact

If enacted, SB1043 will significantly alter current regulations regarding the distribution and administration of opioid overdose reversal medications. The bill likely encourages broader access to these medications, particularly in emergency situations, which could lead to quicker response times in overdose incidents. By supporting easier access for both individuals at risk and first responders, the legislation aims to save lives and improve health outcomes related to opioid overdoses.

Summary

SB1043 relates to the availability and provision of opioid overdose reversal medication. The legislation is designed to enhance public health efforts in combating the opioid crisis by ensuring that tools for overdose reversal, such as naloxone, are readily available to individuals and emergency responders. The bill aims to reduce fatalities associated with opioid overdoses, thereby addressing a significant public health concern in many communities across the state.

Sentiment

The sentiment surrounding SB1043 appears to be largely positive, with a general consensus that increasing access to life-saving medication is a necessary step in addressing the opioid epidemic. Supporters of the bill emphasize its potential to prevent overdose deaths and provide critical support to those struggling with addiction. Nevertheless, there are nuances in the discussions, with some expressing caution regarding the implications of widespread availability and the need for accompanying addiction treatment resources.

Contention

One point of contention discussed around SB1043 involves the balance between accessibility and responsible distribution of opioid reversal medications. Some critics raise concerns that increasing access without adequate education and resources for users may lead to misuse or complacency regarding opioid use. Additionally, there are discussions about the necessity of ensuring that alongside providing medications, there should be an ongoing commitment to addiction recovery programs and public education to effectively combat the broader opioid crisis.

Companion Bills

No companion bills found.

Previously Filed As

OR HB358

AN ACT relating to opioid overdose reversal agents.

OR HB05053

An Act Concerning Opioids And Access To Overdose Reversal Drugs.

OR SB472

Pupil health: opioid overdose reversal medication.

OR LD1728

An Act to Ensure Access to Federally Approved Opioid Overdose-reversing Medication

OR AB2998

Opioid overdose reversal medications: pupil administration.

OR AB1841

Student safety: opioid overdose reversal medication: student housing facilities.

OR HB1174

Public schools; authorize to have a supply of FDA-approved opioid reversal agents on premises to counter opioid overdose.

OR SB367

Student safety: opioid overdose reversal medication.

OR SB00483

An Act Concerning The Prevention And Treatment Of Opioid Dependency And Opioid Overdoses In The State.

OR LD710

An Act to Expand Access and Reduce Barriers to Access to Naloxone Hydrochloride and Other Opioid Overdose-reversing Medications

Similar Bills

No similar bills found.